Future of Pharmacy

The integration of artificial intelligence into health care represents a shift in how pharmacists approach medication management and patient care.

Believe it or not, none of them are pharmacy specific.

The pharmaceutical giant will reportedly lower its drug prices to align with most-favored-nation status.

A hybrid chatbot that evaluates stages of change in pneumococcal vaccination desires while providing artificial intelligence (AI)-based Q&A opportunities improved uptake in older adults.

Student pharmacists should use practical tips to responsibly use artificial intelligence tools for studying, clinical simulations, exam preparation, and time management while ensuring ethical and effective usage.

Martha Thorne discusses the operational, financial, and patient care challenges pharmacies face under the 340B rebate pilot and the need for advocacy, automation, and transparency to sustain access.

For American Pharmacists Month, see how recent instances of conflicting medical advice show the importance of pharmacists as trustworthy health care professionals.

Discover how pharmacists play a crucial role in the OUD treatment process with buprenorphine, enhancing patient care and recovery outcomes.

In an announcement at the White House, Pfizer said it will reduce drug prices in the United States to match those of other countries.

Pharmacists explore virtual solutions for opioid use disorder, enhancing treatment retention and accessibility while addressing economic impacts.

In a recent study, machine learning demonstrated its ability to predict progression to end-stage renal disease among patients with chronic kidney disease (CKD).

Pharmacists face challenges as recent federal policy changes threaten their expanded roles in vaccination and public health, impacting patient access to care.

Don’t be asleep at the wheel. AI is coming, and it’s coming fast.

This milestone celebration not only honors CPA’s legacy but also underscores the profession’s future—one defined by collaboration, innovation, and a steadfast commitment to patient care.

Employers are facing higher costs and employees higher premiums as 340B’s growth drives lost rebates and rising drug prices.

Drug shortages challenge US health care, driven by systemic issues like low pricing and manufacturing concentration, impacting patient care and safety.

Expert emphasizes the need for stronger transparency and patient definitions in the 340B program.

An expert shares how 340B puts independent pharmacies at a competitive disadvantage.

Christopher Lis, senior director at JD Power, shared key insights about the report and what the pharmacy landscape currently looks like.

Virtual health care enhances patient experiences, integrates complex data, and ensures medication access through provider-pharmacist collaboration.

In pharmacy, this model encourages taking responsibility and the open reporting of errors and near-misses without fear of punishment.

The JD Power 2025 US Pharmacy Study reveals rising satisfaction with mail-order pharmacies and supermarkets, driving a shift in prescription fulfillment preferences.

The bill promises lower drug costs and greater innovation, but critics still have concerns.

Brad Cochran of Cardinal Health explains the One Voice Initiative, which aims to bolster independent pharmacies.